[ Price : $8.95]
FDA approves Genentechs Rituxan (rituximab) injection to treat granulomatosis with polyangiitis and microscopic polyangiitis in ch...[ Price : $8.95]
An email distribution by Galt Pharmaceuticals to health professionals draws an FDA Warning Letter on insomnia drug Doral (quazepam...[ Price : $8.95]
FDA approves Abbotts Proclaim XR recharge-free neurostimulation system for people with chronic pain.[ Price : $8.95]
Federal Register notice: FDA announces a 10/31 public meeting on an International Council on Harmonization guideline on clinical t...[ Price : $8.95]
FDA issues new and updated guidances to clarify regulatory oversight of various digital health tools.[ Price : $8.95]
Zogenix resubmits an NDA for Fintepla (fenfluramine hydrochloride) for treating seizures associated with Dravet syndrome.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance on medical device regulatory electronic submissions.[ Price : $8.95]
CDER director Janet Woodcock says Congress has approved the Centers reorganization plan and it is being implemented.